KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Total Liabilities (2016 - 2025)

Historic Total Liabilities for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $136.5 billion.

  • AbbVie's Total Liabilities fell 59.05% to $136.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $136.5 billion, marking a year-over-year decrease of 59.05%. This contributed to the annual value of $131.8 billion for FY2024, which is 601.94% up from last year.
  • As of Q3 2025, AbbVie's Total Liabilities stood at $136.5 billion, which was down 59.05% from $137.3 billion recorded in Q2 2025.
  • AbbVie's Total Liabilities' 5-year high stood at $140.8 billion during Q1 2024, with a 5-year trough of $121.2 billion in Q1 2023.
  • In the last 5 years, AbbVie's Total Liabilities had a median value of $131.8 billion in 2024 and averaged $130.9 billion.
  • In the last 5 years, AbbVie's Total Liabilities skyrocketed by 3869.02% in 2021 and then plummeted by 737.95% in 2022.
  • Over the past 5 years, AbbVie's Total Liabilities (Quarter) stood at $131.1 billion in 2021, then decreased by 7.3% to $121.5 billion in 2022, then grew by 2.3% to $124.3 billion in 2023, then increased by 6.02% to $131.8 billion in 2024, then grew by 3.6% to $136.5 billion in 2025.
  • Its Total Liabilities was $136.5 billion in Q3 2025, compared to $137.3 billion in Q2 2025 and $134.7 billion in Q1 2025.